Patient & Visitor InformationContact Us
  • Cutting-Edge Treatment Options

  • Working with state-of-the-art technology, the Comprehensive Cancer Center's highly trained clinicians offer the most effective cancer treatments available in the world, right here in Rhode Island.

    Trilogy Stereotactic SystemThe Trilogy Stereotactic System is the world's premier image-guided system that allows physicians to pinpoint cancer in the head, neck and body, and use the most effective treatments for each type of cancer. The Comprehensive Cancer Center is the first in the state to offer this powerful system. Trilogy is capable of delivering all forms of external beam radiation.

    Robotic prostatectomy is an effective alternative to traditional open surgery and laparoscopy, with fewer side effects, for prostate cancer treatment.

    Intensity modulated radiation therapy (IMRT) is a noninvasive procedure that uses pinpoint delivery of radiation therapy for various types of cancer, including prostate cancer, head and neck cancers, brain tumors, and some lung and pancreatic cancers. IMRT causes no fatigue, nausea or hair loss and enables better control of radiation to preserve the surrounding healthy tissue.

    A precise and powerful tool, Gamma Knife treats tumors and vascular malformations in the brain. Treatment rarely causes side effects and there is no risk of surgical complications. We were one of the first sites in the United States to use Gamma Knife, and remain one of two facilities in New England to use the technology.

    Radiofrequency ablation (RFA) is a minimally invasive technique that uses heat to destroy tumors. It was designed to destroy liver tumors, but has proven to be successful at eliminating tumors in other parts of the body. We were the first in the country to explore additional applications for RFA. Today, RFA is used successfully to treat breast, kidney, liver, lung, adrenal and bone cancers.

    Combination treatment of radiofrequency ablation and high dose rate brachytherapy, a form of radiation therapy, was first performed at our center. We are now leading a national clinical trial of the combination treatment.

    A minimally invasive procedure, microwave ablation heats and destroys tumors using microwave energy. We performed the first microwave ablation procedure in the United States; we are currently one of only ten facilities in the country that offer the treatment and we are leading the clinical trials.

    Antibody therapies are used for people with compromised immune systems. The center provides Immune Globulin Intravenous therapy; intravenous immunoglobulin is a highly purified preparation of immunoglobulin G and is used in the treatment of patients who have no, or very low levels of, antibody production.

    Electronic brachytherapy is used to treat early stage breast cancer and endometrial cancer using a miniaturized linear accelerator to deliver a radiation-emitting seed the size of a grain of rice directly to the tumor site in order to help reduce recurrence of the disease.

    Chemotherapy is the treatment of cancer with "anticancer" drugs that destroy cancer cells by stopping them from growing or multiplying. The Comprehensive Cancer Center provides chemotherapy in a comfortable, private setting.

    The Lymphedema Program helps patients manage lymphedema through complete decongestive therapy, which includes massage, compression wrapping and patient education.

    The Melanoma Program provides individualized assessments and care plans for each patient to ensure the best possible treatment.

    The Genetic Counseling Center identifies families who have inherited types of cancer, so that at-risk relatives can be monitored.

    Intraperitoneal hyperthermic chemoperfusion (HIPEC) treatment combined with surgical removal of the tumor is an innovative treatment for advanced stage patients with abdominal cancers such as ovarian and gastrointestinal.

    Photo courtesy of Varian Medical Systems, Inc., of Palo Alto, Calif. Copyright 2005, Varian Medical Systems, Inc. All rights reserved.